ERIN MCMANUS: Open Payments
NPI 1912961327 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 87 payments from 14 companies in 2025. Trend: 2023 $776 · 2024 $2,410 · 2025 $2,266
Food & beverage: $2,251Education: $15
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $367 |
| Otsuka America Pharmaceutical, Inc. | 13 | $246 |
| AKEBIA THERAPEUTICS INC | 3 | $236 |
| Calliditas Therapeutics US Inc. | 13 | $221 |
| Fresenius USA Marketing, Inc. | 10 | $221 |
| Travere Therapeutics, Inc. | 13 | $206 |
| Ardelyx, Inc. | 13 | $193 |
| Amgen Inc. | 4 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $129 |
| Novo Nordisk Inc | 2 | $129 |
Products named: Vafseo, JYNARQUE, TARPEYO, VELPHORO, IBSRELA, Vanrafia, TAVNEOS, Kerendia.
Industry payments across IN — which companies pay providers there.
